wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45070965-E8B9F630-FB1A-4685-AA8A-B0CBE0C5C7A0
Q45070965-E8B9F630-FB1A-4685-AA8A-B0CBE0C5C7A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45070965-E8B9F630-FB1A-4685-AA8A-B0CBE0C5C7A0
Key questions to be answered.
P2860
Q45070965-E8B9F630-FB1A-4685-AA8A-B0CBE0C5C7A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45070965-E8B9F630-FB1A-4685-AA8A-B0CBE0C5C7A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41b45fbe9e97d60cb0a9994506d935f90f461c18
P2860
A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.